VEGFA and acute respiratory distress syndrome: Increasing levels of plasma VEGF in acute respiratory distress syndrome (ARDS) are associated with a worse outcome [10], and in animal models, inhibition of VEGF using a soluble receptor to VEGF reduces bleomycin-induced lung injury and fibrosis [11].